| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1002850 |
| landingPage: |
http://www.iedb.org/assay/1341005 |
| type: |
Literature
|
| publicationVenue: |
Vaccine
|
| dates: |
1998
|
| study type: | b cell assays |
| subject species: |
| fullName: |
E H Nardin
J M Calvo-Calle
G A Oliveira
P Clavijo
R Nussenzweig
R Simon
W Zeng
K Rose
|
| method: |
ELISA
|
| name: |
Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
|
| description: |
The CSP B repeat epitopes were combined in tetrabranched, di- and tri-epitope constructs with and without a T-helper epitope. The combined peptide sequence was derived from the CS protein of P. falciparum (NF54).
The (T1BT*)4-polyoxime vaccine formulation containing both B and T cell epitopes elicited high antibody titers in all three mouse strains, even in the absence of the Alum adjuvant. The magnitude of responses was increased by absorption to Alum. MAP-constructed vaccine formulations were poorly immunogenic. Immunogenicity was further enhanced, and kinetics improved, in all three mouse strains by the addition of Pam3Cys. Immunization with the tri-epitope vaccine in Pam3Cys resulted in a good correlation between ELISA titers and reactivity to P. falcioparum sporozoites by immunofluorescence assay (IFA).
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |